Asia-Pacific Women’s Health Diagnostics Market – Industry Trends and Forecast to 2028

 Market Analysis and Insights: Asia-Pacific Women’s Health Diagnostics Market

The women’s health diagnostics market is expected to witness market growth at a rate of 8.9% in the forecast period of 2021 to 2028. Data Bridge Market Research report on women’s health diagnostics market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in healthcare sector globally is escalating the growth of women’s health diagnostics market.

Women’s health is defined as the diagnosis and treatment of conditions and diseases that may affect a woman’s health physically as well as emotionally. Women tend to have issues such as sexually transmitted infections (STIs), breast cancer, birth control, gynecology disorders, and ovarian cancer, among other female cancers. These diagnostics are utilized to analyze and detect these health issues in women such as cervical cancer, bone density screening and breast cancer screening.

The rise in prevalence of infectious diseases in women across the region acts as one of the major factors driving the growth of women’s health diagnostics market. The increase in relevance of early detection of any health issue with help of digital and mobile mammography, such as breast ultrasound, MRI, and bone density testing, and surge in initiatives by government and health organizations accelerate the market growth. The advancements in infrastructure in diagnostic imaging centers because of public-private partnerships, and increased adoption of POC and rapid diagnostic tests further influence the market. Additionally, rise in venture capital investments, surge in healthcare expenditure, increase in population, increased adoption of POC and rapid diagnostic tests and awareness about fertility testing in women positively affects the women’s health diagnostics market. Furthermore, rise in number of regulatory approvals for immunoassay diagnostic techniques extend profitable opportunity to the market players in the forecast period of 2021 to 2028.

On the other hand, high cost associated with the diagnostic imaging systems and procedures, and adoption of refurbished diagnostic imaging systems are expected to obstruct the market growth. Shortage of skilled laboratory technicians and presence of stringent regulatory guidelines are projected to challenge the women’s health diagnostics market in the forecast period of 2021-2028.

This women’s health diagnostics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on women’s health diagnostics market Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Asia-Pacific Women’s Health Diagnostics Market Scope and Market Size

The women’s health diagnostics market is segmented on the basis of application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. 

• On the basis of application, the women’s health diagnostics market is segmented into osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy and fertility testing, prenatal genetic screening and carrier testing, infectious disease testing, STD testing and ultrasound tests. Osteoporosis testing is further segmented into bone densitometry and in vitro blood tests. OVC testing is further segmented into OVC tumor marker tests, OVC diagnostic imaging tests and other OVC tests. Cervical cancer testing is further segmented into pap smears and HPV testing. Breast cancer testing is further segmented into mammography, breast cancer tumor marker tests, biopsies and other breast cancer tests. Pregnancy and fertility testing is further segmented into lab-based testing, pregnancy testing and ovulation prediction kits and fertility monitors. Prenatal genetic screening and carrier testing is further segmented into CF testing, Down’s syndrome and Edwards’ syndrome testing, TORCH testing and other prenatal genetic disease tests. Infectious disease testing is further segmented into MRSA testing, UTI testing, hepatitis testing, tuberculosis testing and other infectious disease tests. STD testing is further segmented into CT/NG testing, HIV testing and other STD tests. Ultrasound tests are further segmented into breast imaging and OB/GYN imaging.
• On the basis of end user, the women’s health diagnostics market is segmented into hospitals, diagnostic and imaging centers, clinics and home care setting.

Asia-Pacific Women’s Health Diagnostics Market Country Level Analysis

The women’s health diagnostics market is analyzed and market size insights and trends are provided by country, application and end user as referenced above.      

The countries covered in the Asia-Pacific women’s health diagnostics market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).

Japan dominates the Asia-Pacific women’s health diagnostics market owning to the technological advancements in the diagnostics in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare infrastructure growth installed base and new technology penetration

Asia-Pacific women’s health diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Asia-Pacific women’s health diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Asia-Pacific women’s health diagnostics market. The data is available for historic period 2010-2019.

Competitive Landscape and Asia-Pacific Women’s Health Diagnostics Market Share Analysis

The women’s health diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to women’s health diagnostics market.

The major players covered in the women’s health diagnostics market report are Siemens, Hologic, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Abbott, BD, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Koninklijke Philips N.V., NeuroLogica Corp., Shimadzu Corporation, bioMérieux SA, Carestream Health, MEDGYN PRODUCTS, INC., URIT MEDICAL ELECTRONIC CO., LTD, COOK, Cardinal Health, PerkinElmer Inc., GENERAL ELECTRIC, Quest Diagnostics Incorporated, Danaher, Sysmex Corporation, Hitachi, Ltd., Canon Inc., FUJIFILM Holdings Corporation and others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-46134